Clinical Trial Update: Efficacy Evaluation of 5-Fluorouracil as an Adjuvant to Endoscopic Dacryocystorhinostomy in Managing Primary Acquired Nasolacrimal Duct Obstruction With Small Lacrimal Sac: A Randomized Controlled Study [NA]

View source ↗

Summary

A randomized controlled trial is evaluating whether adding 5-fluorouracil as an adjuvant to endoscopic dacryocystorhinostomy improves outcomes for primary acqui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Nasolacrimal Duct Obstruction

Drugs mentioned

• 5-Fluorouracil (5-FU)

Snippet

Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University | Conditions: Primary Acquired Nasolacrimal Duct Obstruction | NA | Status: RECRUITING